TokenPost·
Instil Bio Posts $0.62 GAAP Loss Per Share, $0.48 Non-GAAP Loss Per Share

$67.1M
cash position
Instil Bio expects its $67.1 million in cash, cash equivalents, restricted cash, marketable securities and long-term investments to fund its operating plan through 2027.